Novartis said net income increased in the third quarter thanks to proceeds from its consumer health joint venture with GlaxoSmithKline, helping to offset declining revenue and heavy investment in its new heart-failure medicine and its ailing eye-care unit.
from WSJ.com: US Business http://ift.tt/2dEQ92j
via IFTTT
No comments:
Post a Comment